LGR5 marks targetable tumor-initiating cells in mouse liver cancer

Cancer stem cells (CSCs) or tumor-initiating cells (TICs) are thought to be the main drivers for disease progression and treatment resistance across various cancer types. Identifying and targeting these rare cancer cells, however, remains challenging with respect to therapeutic benefit. Here, we rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Wanlu, Li, Meng, Liu, Jiaye, Zhang, Shaoshi, Noordam, Lisanne, Verstegen, Monique M. A., Wang, Ling, Ma, Buyun, Li, Shan, Wang, Wenshi, Bolkestein, Michiel, Doukas, Michael, Chen, Kan, Ma, Zhongren, Bruno, Marco, Sprengers, Dave, Kwekkeboom, Jaap, J. W. van der Laan, Luc, Smits, Ron, Peppelenbosch, Maikel P., Pan, Qiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181628/
https://www.ncbi.nlm.nih.gov/pubmed/32327656
http://dx.doi.org/10.1038/s41467-020-15846-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181628/
https://www.ncbi.nlm.nih.gov/pubmed/32327656
http://dx.doi.org/10.1038/s41467-020-15846-0

Ejemplares similares